| Today | 5d | 1m | 3m | 1y | 5y | 10y |
| Last: | $5.58 | High: | $5.73 |
| Prev Close: | $5.73 | Low: | $5.52 |
| Open: | $5.65 | Mkt Cap: | $525M |
| Change: | -$0.15 ( -2.62% ) | 52Wk High: | $9.24 |
| Vol: | 1,028,481 | 52Wk Low: | $2.48 |
| Avg Volume: | 1,600,966 | Shares: | 91.62B |
| EPS: | -0.82 | PE Ratio: | - |
A biopharmaceutical company, which is developing therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.
|
|
B. Ennis
via Twitter |
Nov 19 9:25 AM |
|
@wsmco GERN has a significant pipeline as well, but all early stage. if you like to accumulate, $GERN nice buy and hold opp...
Comment |
||
|
|
B. Ennis
via Twitter |
Nov 19 8:54 AM |
|
@wsmco maybe $GERN will be the next VVUS, MNKD on my list as well....
Comment |
||
|
|
steve fleischer
via Twitter |
Nov 19 8:24 AM |
|
$GERN Adds 3% on Presentation of Interim Clinical Data On Telomerase Inhibitor Drug for Advanced Cancer Patients 11/19 08:22 AM no position
Comment |
||
|
|
Tim Kathlina
via Twitter |
Nov 19 8:16 AM |
|
$GERN Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI Could see some short covering above 200 day.
Comment |
||
|
|
B. Ennis
via Twitter |
Nov 11 3:21 PM |
|
$GERN nice day, bought not enough to convince me that it won't fill gap down soon....volume?
Comment |
||
Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.
|
||||||||||||||||||||||||||||||